BioNTech (BNTX) PT Lowered to $140 at Wells Fargo

May 6, 2026 8:43 AM

Wells Fargo analyst Mohit Bansal lowered the price target on BioNTech (NASDAQ: BNTX) to $140.00 (from $150.00) while maintaining a Overweight rating.

No results found